# Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients

> **NCT00271284** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 88 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin glulisine / insulin glargine
- **DRUG:** insulin glulisin / insulin detemir

## Key facts

- **NCT ID:** NCT00271284
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2009-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271284, "Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00271284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*